XBiotech (XBIT) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

XBiotech Revenue Highlights


00

Main Segment (Y)

Manufacturing Revenue

XBiotech Revenue by Period


XBiotech Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$4.01M-78.20%
2021-12-31$18.39M-58.19%
2020-12-31$44.00M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

XBiotech generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

XBiotech Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.62M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$300.00K-82.14%
2022-09-30$1.68M9.80%
2022-06-30$1.53M206.00%
2022-03-31$500.00K-88.89%
2021-12-31$4.50M-0.42%
2021-09-30$4.52M-0.13%
2021-06-30$4.53M-6.70%
2021-03-31$4.85M-7.95%
2020-12-31$5.27M-50.05%
2020-09-30$10.55M-31.93%
2020-06-30$15.50M22.21%
2020-03-31$12.68M100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-11-02-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31--

XBiotech generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

XBiotech Revenue Breakdown


XBiotech Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20
Clinical Trial Service Revenue-$394.00K$25.98M
Manufacturing Revenue$4.01M$18.00M$18.00M
Product and Service, Other--$22.00K

XBiotech's latest annual revenue breakdown by segment (product or service), as of Dec 22: Manufacturing Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Manufacturing Revenue$300.00K$1.68M$1.53M$500.00K$4.50M$4.50M$4.50M$4.50M$4.50M$6.00M$4.50M$3.00M
Clinical Trial Service Revenue-----$19.00K$25.00K$350.00K$747.00K$4.55M$11.00M$9.68M

XBiotech's latest quarterly revenue breakdown by segment (product or service), as of Dec 22: Manufacturing Revenue (100.00%).

XBiotech Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Manufacturing Revenue$300.00K$1.68M$1.53M$500.00K$4.50M$4.50M$4.50M$4.50M$4.50M$6.00M$4.50M$3.00M
Clinical Trial Service Revenue-----$19.00K$25.00K$350.00K$747.00K$4.55M$11.00M$9.68M

XBiotech's latest quarterly revenue breakdown by geography, as of Dec 22: Manufacturing Revenue (100.00%).

XBiotech Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TSVT2seventy bio$100.39M$13.53M
STOKStoke Therapeutics$8.78M$4.89M
KZRKezar Life Sciences$7.00M-
KRONKronos Bio$6.29M$2.37M
GBIOGeneration Bio$5.90M$4.09M
ABSIAbsci$5.72M$898.00K
PHATPhathom Pharmaceuticals$682.00K$16.35M
CCCCC4 Therapeutics--
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
REPLReplimune Group--
ERASErasca--
XBITXBiotech--
PASGPassage Bio--
ADVMAdverum Bio--
ONCTOncternal Therapeutics--
EWTXEdgewise Therapeutics--
ELDNEledon Pharmaceuticals--

XBIT Revenue FAQ


What is XBiotech’s yearly revenue?

XBiotech's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $4.01M, representing a decrease of -78.20% compared to 2021. XBIT's yearly revenue for 2021 was $18.39M, representing a decrease of -58.19% compared to 2020.

What is XBiotech’s quarterly revenue?

XBiotech's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). XBIT's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is XBiotech’s revenue growth rate?

XBiotech's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.

What are XBiotech’s revenue streams?

XBiotech's revenue streams in c 22 are Manufacturing Revenue

What is XBiotech’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of XBiotech was Manufacturing Revenue. This segment made a revenue of $4.01M, representing 100.00% of the company's total revenue.